Ardea Biosciences
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Ardea Biosciences sits in the top decile of US sponsors by registered trial count (#513 of 15,742 sponsors by registered trial count).
Ardea Biosciences: 32 sponsored US clinical trials, none currently recruiting.
Ardea Biosciences sponsors 32 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 32 completed. 8 of these trials are in Phase 3-4 (later-stage) and 23 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Gout, with 3 trials.
Top-decile sponsor footprint
Ardea Biosciences ranks in the top decile of sponsors by registered trial count (#513 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
32 of 32 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
32 total, page 1 of 1
Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence
NCT02888054
RDEA3170 PK/PD Study
NCT02608710
Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability
NCT02581553
Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
NCT02498652
RDEA3170 Tablet and Capsule Bioavailability Study
NCT02448368
DECT Study in Allopurinol-Treated Gout Patients
NCT02393560
RDEA3170 and Allopurinol Combination Study in Gout Subjects
NCT02279641
RDEA3170 Bioavailability Study
NCT02336594
RDEA3170 and Febuxostat Combination Study in Gout Subjects
NCT02246673
Mild, Moderate and Severe Renal Impairment Study
NCT02219516
Lesinurad Tablet Bioequivalence
NCT02127775
Bioavailability of Lesinurad and Intravenous [14C]Lesinurad
NCT02039700
Antacid Interaction Study
NCT01982201
Lesinurad Tablet Relative Bioavailability
NCT01986556
Metformin and Furosemide Drug-Drug Interaction Study
NCT02028689
RDEA3170 Monotherapy in Subjects With Gout
NCT01927198
RDEA3170 AME Study
NCT01910506
Lesinurad Interaction Study With Ranitidine
NCT01908257
NSAID Drug Interaction Study
NCT01884272
RDEA3170 and Febuxostat Drug Interaction Study
NCT01883167
Single and Multiple Dose Study in Japanese Subjects
NCT01872832
Lesinurad and Febuxostat Combination Extension Study in Gout
NCT01808144
Lesinurad and Allopurinol Combination Extension Study in Gout
NCT01808131
Single and Multiple Dose Study in Japanese
NCT01744379
Open-Label Lesinurad Monotherapy Extension Study in Gout
NCT01650246
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
NCT01508702
Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
NCT01510769
Combining Lesinurad With Allopurinol in Inadequate Responders
NCT01510158
Combining Lesinurad With Allopurinol in Inadequate Responders
NCT01493531
Allopurinol Outcome Study
NCT01391325
Allopurinol Combination Study
NCT01001338
Gout Dose Response Study
NCT00955981
How the Ardea Biosciences early-phase archive is shaped
32 indexed studies, none listed as recruiting (0% open); 32 completed (100%).
Phase mix: 8 late (III/IV) vs 23 early (I/II) (early-phase heavy).
Top condition: Gout (3 trials), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Ardea Biosciences: archived-pipeline peers nationwide
Peers matched on 32 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Ardea Biosciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 32 archived trials
- Aerie Pharmaceuticals · 32 trials · 0% recruiting
- Allina Health System · 32 trials · 3% recruiting
- Hebrew SeniorLife · 32 trials · 19% recruiting
- MiMedx Group · 32 trials · 3% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Ardea Biosciences page
32 registered trials is a research-attention snapshot, not an endorsement of Ardea Biosciences or any single study.
- None of Ardea Biosciences's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Gout is the condition Ardea Biosciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Gout trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Ardea Biosciences pipeline card: 32 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.